In March 2025, the company introduced new programs for a direct-to-customer supplying of its Wegovy weight loss drug. The company founded a fresh pharmacy, identified as NovoCare, which would charge consumers $499 a month for entry to the drug, fewer than 50 % the cost of the drug through other pharmaceutical distribution networks.[fifty three]Than